Skip to main content
. 2022 Feb 18;23(4):2290. doi: 10.3390/ijms23042290

Figure 8.

Figure 8

Role of lysosomes in human hematopoietic stem cells (HSCs) fate decisions. In quiescent HSCs, enhanced TFEB activity promotes catabolic pathways and lysosome-mediated degradation of membrane receptor involved in the response to mitogen signals, contributing to maintenance of a dormant state. Upon activation, MYC antagonizes TFEB activity, leading to expression of cell cycle, biosynthesis, and mitochondria-related genes, allowing cells to respond to mitogen stimuli by activation of anabolic pathways and subsequent cell cycle re-entry.